NCT03502928 is a NA clinical trial of Motor Control in Whiplash Injuries, sponsored by University of Alcala.

Who is sponsoring NCT03502928?

NCT03502928 is sponsored by University of Alcala.

What drugs are being tested in NCT03502928?

Interventions in NCT03502928: Motor Control, Manual Therapy, Dry Needling.

What condition does NCT03502928 study?

NCT03502928 studies Whiplash Injuries.

Is NCT03502928 still recruiting?

NCT03502928 is currently completed. Last updated 11 June 2020.

Last reviewed 2020-06-11 · How we verify

NCT03502928

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of the Use of Dry Needling in Conventional Non-invasive Treatment of Acute and Subacute Whiplash

Completed NA Last updated 11 June 2020

What this trial tests

NA trial testing Motor Control in Whiplash Injuries in 30 participants. Completed in 10 June 2020.

Timeline

4 November 2019

Primary endpoint
16 January 2020

10 June 2020

Quick facts

Lead sponsor	University of Alcala
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	4 November 2019
Primary completion	16 January 2020
Estimated completion	10 June 2020
Sites	1 location across Spain

Drugs / interventions tested

Motor Control
Manual Therapy
Dry Needling

Conditions studied

Whiplash Injuries — all drugs for Whiplash Injuries →

Sponsor

University of Alcala

Who can join

Adults 18 to 65, any sex, with Whiplash Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

INTRODUCTION: Whiplash is an injury produced by an acceleration-deceleration mechanism that transmits energy to the cervical spine. According to the bibliography, the conservative treatment (motor control exercises and manual therapy) has shown benefits in approaching this lesion, but its efficacy is limited. Dry needling has already shown its usefulness in different musculoskeletal pathologies, however, its efficacy is unknown when it is included in conservative treatment. OBJECTIVES: The objective of this study is to assess the effects of the incorporation of dry needling in the conventional treatment with manual therapy and motor control exercises, compared to the conventional non-invasive treatment in patients with acute or subacute whiplash. HYPOTHESIS: The inclusion of dry needling in conventional non-invasive treatment is more effective than conventional non-invasive treatment in patients with acute or subacute whiplash. METHODS: A randomized clinical trial will be conducted in which the subjects of study will be assigned to two groups, a control group (conventional treatment) and an experimental group (conventional treatment and dry needling).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Whiplash Injuries

Currently open trials in the same condition.

NCT06502951 — Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II · NA · recruiting

Other University of Alcala trials

Trials by the same sponsor.

NCT06599164 — Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury · not yet recruiting
NCT06587412 — Treatment of Lateral Epicondylalgia With Shock Waves · NA · recruiting
NCT07333443 — Caffeine and Sport Climbing Performance · NA · completed
NCT07015008 — Sleep and Maximal Fat Oxidation · NA · completed
NCT06723821 — Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03502928 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alcala
Last refreshed: 11 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03502928.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing